A phosphorylated, nonstructural protein of bluetongue virus, NS2, is synthesized throughout the replication cycle in comparatively large amounts. The protein was detected in both the soluble and particulate fraction of the cytoplasm of infected cells. The particulate NS2 could be solubilized in 0.5 M NaCi. It Huismans, submitted for publication). These include the seven structural proteins, P1 to P7, and three distinct nonstructural proteins, NS1, NS2, and NS3. Two NS3 peptides, NS3 and NS3A, with molecular weights of 28,000 and 25,000, respectively, can be distinguished. They are both coded for by segment 10 and have almost identical peptide maps. Furthermore, a fourth possible nonstructural protein, designated NS4, has been identified. This protein has a molecular weight of about 16,000, and indications are that it is coded for by genome segment 9, which also codes for structural protein P6 (van Dijk and Huismans, submitted).
phosphorylated in vitro. It is not known whether the kinase involved is of cellular or viral origin, but after purification of NS2 by affinity chromatography on poly(U)-Sepharose it could still by phosphorylated in vitro Without the addition of exogenous protein kinase. The affinity of NS2 for nucleic acid was also investigated. The protein was found to bind to single-stranded RNA. In the presence of purified bluetongue virus mRNA, NS2 formend a complex with an estimated S value of about 22S.
Bluetongue virus (BTV) is the prototype species of the genus Orbivirus and a member of the family Reoviridae (20) . The genome consists of 10 segments of double-stranded RNA (dsRNA), each of which is transcribed into mRNA by a core-associated dsRNA-dependent RNA polymerase (12, 19) . At least 10 translation products of the BTV mRNA species have been identified (14; A. A. van Dijk and H. Huismans, submitted for publication). These include the seven structural proteins, P1 to P7, and three distinct nonstructural proteins, NS1, NS2, and NS3. Two NS3 peptides, NS3 and NS3A, with molecular weights of 28,000 and 25,000, respectively, can be distinguished. They are both coded for by segment 10 and have almost identical peptide maps. Furthermore, a fourth possible nonstructural protein, designated NS4, has been identified. This protein has a molecular weight of about 16,000, and indications are that it is coded for by genome segment 9, which also codes for structural protein P6 (van Dijk and Huismans, submitted).
We are interested in relationship between structure and function of the different BTV-specific nonstructural proteins. Very little is known about these proteins. The morphologically best-characterized protein is NS1, which is synthesized in very large amounts and accumulates in BTVinfected cells as tubular structures of various lengths and a side-to-side diameter of 68 nm (9) . Nothing is known about the function of NS1, but it has been shown that it is coded for by one of the most highly conserved of the BTV genome segments (8a).
The other major nonstructural protein, protein NS2, is also synthesized in large amounts. Preliminary investigations have indicated a resemblance to aNS of reovirus in that NS2 has an affinity for single-stranded RNA (ssRNA) (8) . Such ssRNA-binding nonstructural proteins with a molecular weight of about 40,000 appear to be common to all members of the Reoviridae family and have also been demonstrated in the case of rotavirus (2) .
In the case of reovirus, uNS binds to reovirus mRNA (10) to form a 19S complex (5) . The protein appears to play an * Corresponding author. early role in reovirus replication (13) , and it is possible that it acts in the selection and condensation of the 10 mRNA species. The main distinction between BTV NS2 and the nonstructural protein equivalents in the other members of the Reoviridae family is that NS2 appears to be phosphorylated (8) .
These preliminary results prompted a more detailed investigation of the phosphorylation of NS2 and the ability of NS2 to hind to ssRNA. We have purified NS2 by affinity chromatography and were able to show that purified NS2 can be phosphorylated in vitro without the addition of an exogenous protein kinase. The isolation of a 22S BTV mRNA-NS2 complex is also described.
MATERIALS AND METHODS Cells and virus. The BHK-21 cells used in the investigation were grown as monolayers in Roux flasks, by using modified Eagle medium supplemented with 5% bovine serum. An attenuated strain of BTV serotype 10 (designated 10A) was used throughout the study. It was propagated in the BHK cells by using a plaque-purified, low-passage stock virus suspension (7) .
Preparation of 35S-and 32P-labeled S100 and P100 fractions from BTV-infected cells. 4°C , it was further diluted to 1.5 ml with 0.1 STE and filtered through 0.45-,um-pore-size nitrocellulose filter disks (Millipore Corp., Bedford, Mass.). The filters were washed at least four times with 5 ml of 0.1 STE, dried, and counted.
Poly(U)-Sepharose affinity chromatography. A 4-cm poly(U)-Sepharose 4B column in a Pasteur pipette was equilibrated in 0.01 STE buffer containing 10 mM 2-mercaptoethanol. Before being loaded onto the column the salt concentratiois of the S100 or SW fractions were adjusted by dilution with 0.01 STE to 0.2 M NaCI. Samples were loaded on the column at a rate of 0.1 ml/min and washed with equilibration buffer until, as measured by optical density and radioactivity, the eluate was reduced to background levels. A linear gradient of 0.15 to 1.15 STE with 10 mM 2-mercaptoethanol was then applied to the column. Peak fractions were pooled as indicated and analyzed by SDS-15% polyacrylamide gel electrophoresis (PAGE) by using the Laemmli buffer system (11). Proteins were concentrated by dialysis and lyophilization or alternatively by potassium chloride-SDS precipitation (11) .
In vitro phosphorylation assay. In vitro kinase activity was assayed by using MTD buffer (0.01 M Tris hydrochloride [pH 8 .0], 0.01 M MgCl2, 0.01 M dithiothreitol) containing 0.2 ,uCi of [y-32P]ATP (1 mCi/ml; 5, 200 Ci/mol) as described by Moyer and Summers (15) . The final assay mixture was obtained by mixing equal amounts of sample and 2x concentrated MTD buffer. The mixtures were incubated at 37°C for 30 min. 32p incorporation was detected by SDS-PAGE and autoradiography. Phosphoproteins that were labeled with both 35S and 32p were characterized by a method which makes it possible to distinguish by autoradiography between 32p and 35S-labeled components by using a 0.015-mm-thick sheet of aluminum foil to deflect 35S radiation (4).
RESULTS
Identification of NS2 in infected cells. The synthesis of virus-specific proteins in BTV-infected cells from 2 to 28 h postinfection (p.i.) is shown in Fig. 1A . On discontinuous SDS-polyacrylamide gels in a Tris-glycine buffer system, protein NS2 of BTV migrates in a position between proteins NS1 and P6 of BTV. This is different from the relative electrophoretic mobility of NS2 (formerly called P6A) on phosphate-buffered polyacrylamide gels in the presence of urea. On these gels, NS2 has a higher electrophoretic mobility than P6 and migrates in a position that coincides with that of a major labeled cellular protein (7) . This has previously severely handicapped accurate assessment of the time when NS2 is synthesized.
The 35S-methionine pulse-labeling experiment (Fig. 1A) illustrates that at a temperature of 31°C the majority of virus-specified proteins, including NS2, are synthesized between 11 and 22 h p.i. Synthesis of cellular proteins declines very rapidly after 13 h p.i., and from 15 h p.i. almost all protein synthesis is virus specified.
A similar pulse-labeling experiment using 32Pi as labeled precursor was also done. Proteins in the soluble (S10O) fraction of the cytoplasm were analyzed by immunoprecipitation with a BTV-specific immune serum. The results are shown in Fig. 1B . Protein NS2 is the only 32P-labeled virus protein. The intensity of the labeling at the different intervals after infection appears to coincide with that of the 35S-labeled NS2, indicating that NS2 is phosphorylated throughout the infection cycle.
Partial purification of NS2. 32P-labeled NS2 is also present in the particulate fraction of infected cells (Fig. 2, lane a) . This fraction, however, also contains a large number of 32P-labeled cellular proteins as well as 32P-labeled dsRNA. The corresponding 35S-labeled proteins are shown in lane c (Fig. 2) . The particulate NS2 was solubilized by treatment with 0.5 M NaCl. This resulted in a partial purification of NS2 after removal of the particulate 35S-labeled viral proteins (Fig. 2 , lane e). The majority of the small 32P-labeled cellular proteins and dsRNA was also removed (Fig. 2 and then analyzed for their ability to bind BTV mRNA, BTV dsRNA, and cellular ssRNA, respectively (Fig. 3) . It is evident that a component in the SW fraction of BTV-infected cells binds both to the cellular ssRNA and to BTV mRNA.
In the presence of an excess of SW fraction, most of the BTV mRNA and cellular RNA was bound to the nitrocellulose filters.
To identify the binding component, fixed amounts of 35S-labeled SW fractions from BTV-infected cells were mixed with different quantities of 3H-labeled BTV mRNA and analyzed by zonal centrifugation in sucrose gradients under the conditions described in the legend to Fig. 4 was contaminated with a large number of low-molecularweight polypeptides. Therefore, a low pH for the elution buffer is not recommended.
The highest yields of NS2 from affinity column purifications were obtained from SW fractions. However, the method was found to be equally applicable to purifying NS2 from soluble fractions of BTV-infected cells as well as to NS2 synthesized in vitro in a cell-free protein synthesis system (results not shown). The method has also been used to purify 32P-labeled NS2.
In vitro phosphorylation of NS2. To characterize the kinase associated with the phosphorylation of NS2, it was investigated whether NS2 could be phosphorylated in vitro as has been described for the vesicular stomatitis virus phosphoprotein NS (1). 35S-labeled particulate (P100) and soluble (S100) protein extracts were prepared from the cytoplasm of uninfected and BTV-infected BHK cells. The soluble pro- teins in the S100 extracts were concentrated by immunoprecipitation with a BTV-specific serum. The different P100 fractions and immunoprecipitates of the S100 fractions were incubated in a phosphorylation mixture containing [y-32P]ATP and then analyzed as indicated in the legend to Fig.  7 . The result is shown in Fig. 7 .
The results indicate that a protein migrating in the position of NS2 was phosphorylated in both the S100 immunoprecipitate and the P100 fraction of BTV-infected cells (lanes b and d). It is also evident from Fig. 7 that several nonviral proteins were phosphorylated. Since these proteins were observed in both the infected and the uninfected controls, the presence of a cellular protein kinase in the cellular extracts is implicated.
To obtain more information about the kinase involved, NS2 was purified from a 35S-labeled S100 fraction of BTVinfected cells by affinity chromatography as described in the legend to Fig. 6 . The 35S-labeled NS2 was concentrated from the high-salt column wash fractions by immunoprecipitation. The immunoprecipitate was assayed for in vitro kinase activity as indicated in the legend to Fig. 8 .
Conditions for autoradiography were selected to discriminate between 35S-and 32P-labeled proteins. It is evident Autoradiogram showing in vitro kinase activity in a poly(U)-Sepharose-purified NS2 preparation. 35S-labeled NS2 was purified from the S100 fraction of BTV-infected cells by poly(U)-Sepharose column chromatography as described in the legend to Fig. 6 . The viral proteins present in the NS2-containing peak fractions that eluted at 0.5 M NaCl were concentrated by immunoprecipitation and assayed for kinase activity as described in the legend to Fig. 7 On phosphate-urea gels it has a higher electrophoretic mobility than P6 (7), whereas on Tris-glycine gels it migrates slower than P6. It has also been observed that on the latter gels NS2 very often separates into two very closely spaced bands. This is suggestive of posttranslational modifications such as phosphorylation or glycosylation. There is no evidence for the glycosylation of NS2, but it has been found that NS2 is the only virus-specified protein that is phosphorylated. The presence of phosphorylated proteins has been demonstrated in many viruses, and in a number of cases the degree of phosphorylation seems to determine the extent of binding to viral nucleic acid (3, 16) .
In the case of BTV, it was found that a component in the SW fraction of BTV-infected cells that contained NS2 as the major viral protein could bind to ssRNA but not to dsRNA.
A complex with an estimated S value of 22S containing NS2 as the sole protein component could be recovered from mixtures of BTV SW fractions and BTV mRNA. The S value of the complex was found to be independent of the mRNA/NS2 ratio. The narrow size distribution of the complex was rather surprising, in view of the heterogeneous size distribution of BTV mRNA. An equally heterogeneous size distribution of the BTV mRNA-NS2 complex would have been expected if the number of NS2 molecules that are bound to each mRNA were dependent solely on the length of the mRNA species. The possibility that only a limited number of NS2 molecules can bind to each mRNA, as has been found in the case of reovirus (uNS (17) , needs to be investigated. It is also possible that only certain of the mRNA species bind NS2 effectively. Experiments with individual mRNA species and highly purified NS2 of known specific activity are in progress to investigate this particular aspect in more detail.
The affinity of NS2 for mRNA suggests that the NS2 in infected cells is also bound to BTV mRNA or cellular ssRNA. The S value of such complexes is small, and they are therefore likely to be present in the soluble (S100) fraction of infected cells. The largest amount of NS2 is, however, not found in the soluble fraction but appears to be associated with particulate material. Most of these NS2-associated particles sediment through a 40% sucrose cushion after centrifugation at 100,000 x g for 1 h. Some of the NS2 is also bound to low-density material that can be recovered from the top of the 40% sucrose cushion. NS2 is therefore a "sticky" protein, which might also explain the nonspecific coprecipitation of NS2 that is often observed during the immunoprecipitation of BTV proteins (11) .
The particulate fraction of BTV-infected cells has been used as starting material in the purification of NS2. It was found that, similar to particulate oNS in the case of reovirus (10) , BTV NS2 can be solubilized from all particulate material by an SW with 0.5 M NaCI. If this treatment is done at a pH of 8.0 or more, the BTV capsid proteins are not solubilized (11) and a significant purification of the NS2 from other viral and cellular proteins is achieved. The subsequent purification by poly(U)-Sepharose affinity chromatography resulted in a fraction that contained NS2 as the only labeled component. Serva blue-stained polyacrylamide gels, however, often indicated the presence of very small trace amounts of contaminating cellular proteins.
This report presents the first evidence that NS2 can be phosphorylated in vitro. It was shown that immunoprecipitates of BTV-specific proteins from the S100 fraction of infected cells contained a protein kinase that was able to phosphorylate NS2. Similar results have been reported for the NS protein of vesicular stomatitis virus (1) . It was also found that NS2 in the P100 fraction of BTV-infected cells can be phosphorylated in vitro. However, a number of cellular proteins are also phosphorylated under these conditions. Results presented in this report also indicate that in vivo phosphorylation of NS2 takes place throughout the infection cycle. This implies that the in vitro 32p labeling of already phosphorylated NS2 is caused either by hyperphosphorylation or by some form of phosphate exchange as the result of a dynamic phosphorylation-dephosphorylation reaction. To investigate this aspect, we attempted to phosphorylate NS2 synthesized in an in vitro translation reaction (results not shown). No phosphorylation could be demonstrated. These results are again in agreement with those obtained with vesicular stomatitis virus (6) . An experiment was also done in which in vivo-synthesized NS2 was purified to separate it from the kinase activity. It was, however, found that poly(U)-Sepharose-purified NS2 preparations still contained kinase activity that phosphorylated NS2 in vitro. The most likely explanation is that the kinase is one of the minor cel!ular proteins that were often found to be associated with purified NS2. Since a very small amount of P1 was also often seen to be present in purified NS2 preparations, the possibility of a viral protein kinase or even autophosphorylation cannot be excluded. This aspect is under investigation.
